| Gulanna Bernadette Vandross, CRNA | |
|
9263 Medical Plaza Dr Ste E, Charleston, SC 29406 | |
| (843) 572-1228 | |
| Not Available |
| Full Name | Gulanna Bernadette Vandross |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 12 Years |
| Location | 9263 Medical Plaza Dr Ste E, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1245506047 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 17786 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Roper St Francis Hospital-berkely Inc | Moncks corner, SC | Hospital |
| Bon Secours-st Francis Xavier Hospital | Charleston, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bon Secours St Francis Xavier Hospital Inc | 8325008717 | 164 |
News Archive
The Methodist Hospital Outpatient Rehabilitation Center now offers an advanced rehabilitation system for the treatment of foot drop in people with mobility issues caused by stroke, traumatic brain injury, multiple sclerosis, cerebral palsy and spinal cord injury.
Scientists want to know more about how an inexpensive, low-risk treatment may improve recovery from the most deadly type of stroke.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Researchers from Tel Aviv University and Tel Aviv Sourasky Medical Center (Ichilov Hospital) have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited condition that affects adolescents and young adults and often leads to colorectal cancer.
› Verified 7 days ago
| Entity Name | Coastal Anesthesia Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1942252176 PECOS PAC ID: 9032022744 Enrollment ID: O20031110000173 |
News Archive
The Methodist Hospital Outpatient Rehabilitation Center now offers an advanced rehabilitation system for the treatment of foot drop in people with mobility issues caused by stroke, traumatic brain injury, multiple sclerosis, cerebral palsy and spinal cord injury.
Scientists want to know more about how an inexpensive, low-risk treatment may improve recovery from the most deadly type of stroke.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Researchers from Tel Aviv University and Tel Aviv Sourasky Medical Center (Ichilov Hospital) have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited condition that affects adolescents and young adults and often leads to colorectal cancer.
› Verified 7 days ago
| Entity Name | Prisma Health-midlands |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1205889458 PECOS PAC ID: 6800708330 Enrollment ID: O20031110000506 |
News Archive
The Methodist Hospital Outpatient Rehabilitation Center now offers an advanced rehabilitation system for the treatment of foot drop in people with mobility issues caused by stroke, traumatic brain injury, multiple sclerosis, cerebral palsy and spinal cord injury.
Scientists want to know more about how an inexpensive, low-risk treatment may improve recovery from the most deadly type of stroke.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Researchers from Tel Aviv University and Tel Aviv Sourasky Medical Center (Ichilov Hospital) have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited condition that affects adolescents and young adults and often leads to colorectal cancer.
› Verified 7 days ago
| Entity Name | Trident Anesthesia Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376595520 PECOS PAC ID: 5294631545 Enrollment ID: O20031209000391 |
News Archive
The Methodist Hospital Outpatient Rehabilitation Center now offers an advanced rehabilitation system for the treatment of foot drop in people with mobility issues caused by stroke, traumatic brain injury, multiple sclerosis, cerebral palsy and spinal cord injury.
Scientists want to know more about how an inexpensive, low-risk treatment may improve recovery from the most deadly type of stroke.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Researchers from Tel Aviv University and Tel Aviv Sourasky Medical Center (Ichilov Hospital) have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited condition that affects adolescents and young adults and often leads to colorectal cancer.
› Verified 7 days ago
| Entity Name | Medical University Hospital Authority |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255305876 PECOS PAC ID: 1557268950 Enrollment ID: O20031215000499 |
News Archive
The Methodist Hospital Outpatient Rehabilitation Center now offers an advanced rehabilitation system for the treatment of foot drop in people with mobility issues caused by stroke, traumatic brain injury, multiple sclerosis, cerebral palsy and spinal cord injury.
Scientists want to know more about how an inexpensive, low-risk treatment may improve recovery from the most deadly type of stroke.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Researchers from Tel Aviv University and Tel Aviv Sourasky Medical Center (Ichilov Hospital) have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited condition that affects adolescents and young adults and often leads to colorectal cancer.
› Verified 7 days ago
| Entity Name | Bon Secours St Francis Xavier Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1740502822 PECOS PAC ID: 8325008717 Enrollment ID: O20100607000884 |
News Archive
The Methodist Hospital Outpatient Rehabilitation Center now offers an advanced rehabilitation system for the treatment of foot drop in people with mobility issues caused by stroke, traumatic brain injury, multiple sclerosis, cerebral palsy and spinal cord injury.
Scientists want to know more about how an inexpensive, low-risk treatment may improve recovery from the most deadly type of stroke.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Researchers from Tel Aviv University and Tel Aviv Sourasky Medical Center (Ichilov Hospital) have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited condition that affects adolescents and young adults and often leads to colorectal cancer.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Gulanna Bernadette Vandross, CRNA 9263 Medical Plaza Dr Ste E, Charleston, SC 29406-7112 Ph: (843) 572-1228 | Gulanna Bernadette Vandross, CRNA 9263 Medical Plaza Dr Ste E, Charleston, SC 29406 Ph: (843) 572-1228 |
News Archive
The Methodist Hospital Outpatient Rehabilitation Center now offers an advanced rehabilitation system for the treatment of foot drop in people with mobility issues caused by stroke, traumatic brain injury, multiple sclerosis, cerebral palsy and spinal cord injury.
Scientists want to know more about how an inexpensive, low-risk treatment may improve recovery from the most deadly type of stroke.
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 2 study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism (SHPT), which is a frequent and serious complication of end-stage renal disease (ESRD).
Researchers from Tel Aviv University and Tel Aviv Sourasky Medical Center (Ichilov Hospital) have developed an innovative drug treatment for familial adenomatous polyposis (FAP), a rare, inherited condition that affects adolescents and young adults and often leads to colorectal cancer.
› Verified 7 days ago
Christopher Arnold Hensley, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Linda G Dancy, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Sallie B Beam, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 9263 Medical Plaza Dr, Ste E, Charleston, SC 29406 Phone: 843-572-1228 Fax: 877-561-7564 | |
Ginger L Brister, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 2095 Henry Tecklenburg Dr, Charleston, SC 29414 Phone: 843-876-5746 | |
Mrs. Tammie Ann Stahl, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 2095 Henry Tecklenburg Dr, Charleston, SC 29414 Phone: 843-402-1436 Fax: 843-402-1833 | |
Helen E Harman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Annette W Cooper, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 9326 Medical Plaza Dr, Ste B, Charleston, SC 29406 Phone: 843-553-7070 Fax: 843-553-2223 |